ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.

Autor: Perréard M; Normandy University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA laboratory (Precision medicine for ovarian cancers), Comprehensive Cancer Center François Baclesse, 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Department of Head and Neck Surgery, Caen University Hospital, Caen, France., Florent R; Normandy University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA laboratory (Precision medicine for ovarian cancers), Comprehensive Cancer Center François Baclesse, 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Normandy University, UNICAEN, SF Normandy Oncology, US PLATON, ORGAPRED core facility, Caen, France., Divoux J; Normandy University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA laboratory (Precision medicine for ovarian cancers), Comprehensive Cancer Center François Baclesse, 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Normandy University, UNICAEN, SF Normandy Oncology, US PLATON, ORGAPRED core facility, Caen, France., Grellard JM; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Clinical Research Department, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Lequesne J; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Clinical Research Department, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Briand M; Normandy University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA laboratory (Precision medicine for ovarian cancers), Comprehensive Cancer Center François Baclesse, 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Biological Resource Center 'OvaRessources', Caen, France., Clarisse B; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Clinical Research Department, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Rousseau N; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; IRCBN Institut Régional du cancer Basse Normandie, Biological Resource Center 'Tumorotheque de Caen Basse-Normandie', Caen, France., Lebreton E; Clinical Research Department, Caen University Hospital, Caen, France., Dubois B; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, North-West Canceropole Data Center, Caen, France., Harter V; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, North-West Canceropole Data Center, Caen, France., Lasne-Cardon A; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Department of Head and Neck Surgery, UNICANCER, Comprehensive Cancer Center François Baclesse, 3 avenue du Général Harris, Caen, 14000, France., Drouet J; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Department of Oral and Maxillofacial Surgery, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Johnson A; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Department of Medical Oncology Surgery, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Le Page AL; Department of Pathology, Caen University Hospital, Caen, France., Bazille C; Department of Pathology, Caen University Hospital, Caen, France., Jeanne C; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Department of Biopathology, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Figeac M; University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France., Goardon N; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Department of Cancer Biology and Genetics, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Vaur D; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Department of Cancer Biology and Genetics, UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Micault E; Department of Head and Neck Surgery, Caen University Hospital, Caen, France., Humbert M; Department of Head and Neck Surgery, Caen University Hospital, Caen, France., Thariat J; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; LPC Caen ENSICAEN/CNRS UMR6534, Caen, France., Babin E; Normandy University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA laboratory (Precision medicine for ovarian cancers), Comprehensive Cancer Center François Baclesse, 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; Department of Head and Neck Surgery, Caen University Hospital, Caen, France., Poulain L; Normandy University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA laboratory (Precision medicine for ovarian cancers), Comprehensive Cancer Center François Baclesse, 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Normandy University, UNICAEN, SF Normandy Oncology, US PLATON, ORGAPRED core facility, Caen, France., Weiswald LB; Normandy University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA laboratory (Precision medicine for ovarian cancers), Comprehensive Cancer Center François Baclesse, 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France. lb.weiswald@baclesse.unicancer.fr.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France. lb.weiswald@baclesse.unicancer.fr.; Normandy University, UNICAEN, SF Normandy Oncology, US PLATON, ORGAPRED core facility, Caen, France. lb.weiswald@baclesse.unicancer.fr., Bastit V; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France. bastit-v@chu-caen.fr.; Department of Head and Neck Surgery, UNICANCER, Comprehensive Cancer Center François Baclesse, 3 avenue du Général Harris, Caen, 14000, France. bastit-v@chu-caen.fr.

Publikováno v: BMC cancer [BMC Cancer] 2023 Mar 09; Vol. 23 (1), pp. 223. Date of Electronic Publication: 2023 Mar 09.

Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1.

Autor: Galland L; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.; Medical school, University of Burgundy-Franche Comté, Maison de l'université Esplanade Erasme, Dijon, Burgundy, France.; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France., Le Page AL; Department of Pathology, Caen University Hospital, Normandy University, Caen, France., Lecuelle J; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France., Bibeau F; Department of Pathology, Caen University Hospital, Normandy University, Caen, France., Oulkhouir Y; Service de Pneumologie, Caen University Hospital, Caen, France., Derangère V; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.; Medical school, University of Burgundy-Franche Comté, Maison de l'université Esplanade Erasme, Dijon, Burgundy, France.; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, France.; Umr Inserm 1231, Dijon, France., Truntzer C; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, France.; Umr Inserm 1231, Dijon, France., Ghiringhelli F; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.; Medical school, University of Burgundy-Franche Comté, Maison de l'université Esplanade Erasme, Dijon, Burgundy, France.; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, France.; Umr Inserm 1231, Dijon, France.

Publikováno v: Oncoimmunology [Oncoimmunology] 2021 Aug 02; Vol. 10 (1), pp. 1957603. Date of Electronic Publication: 2021 Aug 02 (Print Publication: 2021).

Usefulness of Flow Cytometry for the Detection of Cutaneous Localization in Malignant Hematologic Disorders.

Autor: Maitre E; Laboratoire d'hématologie, CHU de Caen, Calvados, 14033 Caen, France., Le-Page AL; Laboratoire d'Anatomopathologie, CHU de Caen, Calvados, 14033 Caen, France., Comoz F; Laboratoire d'Anatomopathologie, CHU de Caen, Calvados, 14033 Caen, France., Truquet F; Laboratoire d'hématologie, CHU de Caen, Calvados, 14033 Caen, France., Damaj G; Institut d'Hématologie Bas Normand, CHU de Caen, Calvados, 14033 Caen, France., Cornet E; Laboratoire d'hématologie, CHU de Caen, Calvados, 14033 Caen, France., Verneuil L; Service de dermatologie, CHU de Caen, Calvados,14033 Caen, France., Salaün V; Laboratoire d'hématologie, CHU de Caen, Calvados, 14033 Caen, France., Troussard X; Laboratoire d'hématologie, CHU de Caen, Calvados, 14033 Caen, France.; Institut d'Hématologie Bas Normand, CHU de Caen, Calvados, 14033 Caen, France.

Publikováno v: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2019 Jul; Vol. 96 (4), pp. 283-293. Date of Electronic Publication: 2019 May 03.

Enhancing maize growth through the synergistic impact of potassium enrich biochar and spermidine.

Autor: Huang, Shoucheng¹ (AUTHOR), Huang, Ping² (AUTHOR), Masood, Sajid³ (AUTHOR), Iqbal, Muhammad Mazhar⁴ (AUTHOR), Naz, Tayyaba⁵ (AUTHOR), Danish, Subhan³ (AUTHOR) sd96850@gmail.com, Ansari, Mohammad Javed⁶ (AUTHOR), Salmen, Saleh H.⁷ (AUTHOR)

Publikováno v: BMC Plant Biology. 1/9/2024, Vol. 24 Issue 1, p1-18. 18p.

Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study.

Autor: Naoya Nishioka, Hayato Kawachi, Tadaaki Yamada, Motohiro Tamiya, Yoshiki Negi, Yasuhiro Goto, Akira Nakao, Shinsuke Shiotsu, Keiko Tanimura, Takayuki Takeda, Asuka Okada, Taishi Harada, Koji Date, Yusuke Chihara, Isao Hasegawa, Nobuyo Tamiya, Taiki Masui, Natsuki Sai, Masaki Ishida, Yuki Katayama

Publikováno v: Frontiers in Immunology; 2024, p1-9, 9p